BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $488,754 | +61.3% | 69,033 | +187.2% | 0.01% | +11.1% |
| Q3 2022 | $303,000 | +27.8% | 24,034 | +65.2% | 0.01% | +28.6% |
| Q1 2022 | $237,000 | +51.0% | 14,548 | +28.7% | 0.01% | +40.0% |
| Q4 2021 | $157,000 | -79.6% | 11,308 | -76.8% | 0.01% | -84.8% |
| Q2 2021 | $769,000 | +605.5% | 48,641 | +231.8% | 0.03% | +725.0% |
| Q4 2020 | $109,000 | +127.1% | 14,658 | +5.0% | 0.00% | +100.0% |
| Q3 2020 | $48,000 | -33.3% | 13,964 | -7.8% | 0.00% | 0.0% |
| Q2 2020 | $72,000 | +26.3% | 15,140 | -46.6% | 0.00% | 0.0% |
| Q1 2020 | $57,000 | -94.6% | 28,368 | -77.6% | 0.00% | -84.6% |
| Q1 2017 | $1,063,000 | +431.5% | 126,553 | +551.5% | 0.01% | +550.0% |
| Q4 2015 | $200,000 | – | 19,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |